PetVivo Holdings, Inc. (OTCQX:PETV)
PetVivo Holdings, Inc. (OTCQX: PETV) ("PetVivo"), a developing biomedical device enterprise concentrating on bringing innovative medical devices and therapeutics to market for horses and companion animals, has revealed its plans to take part as an exhibitor at the 2026 Fetch Kansas City Veterinary Conference (“Fetch”), scheduled for August 28–30, 2026, at the Kansas City Convention Center in Kansas City, Missouri.
During the conference, PetVivo will display its SPRYNG® with OsteoCushion® Technology, an intra-articular injectable veterinary device composed of sterilized extracellular matrix microparticles. These microparticles are engineered to adhere to the joint’s synovial lining and then merge with the animal’s subsynovial tissue. This process is intended to aid in restoring proper joint function and assist in managing noninfectious causes of joint discomfort, such as joint instability, degenerative joint disease, and osteoarthritis.
“Fetch Kansas City brings together veterinary professionals who are actively seeking new approaches to improve the care and quality of life of their patients,” said John Lai, Chief Executive Officer of PetVivo Holdings, Inc. “We look forward to engaging directly with practitioners, sharing the growing clinical experience with Spryng and discussing how its unique OsteoCushion Technology can provide veterinarians with an additional option for managing osteoarthritis and other causes of joint-related pain. Conferences such as Fetch are an important part of our strategy to build awareness, strengthen relationships within the veterinary community and support the continued adoption of Spryng.”
Additional details about PetVivo Holdings, Inc. are available by reaching out to info1@petvivo.com or browsing https://petvivo.com/, https://www.petvivoanimalhealth.com/, and https://www.sprynghealth.com.
Event Information:
2026 Fetch Kansas City Veterinary Conference Exhibit Details:
Dates:
Friday, August 28, 2026, 10:15am – 6:30pm
Saturday, August 29, 2026, 10:15am – 4:45pm
Sunday, August 30, 2026, 8:00am – 11:00pm
Booth #: 916
Location: Kansas City Convention Center in Kansas City, Missouri
About PetVivo Holdings, Inc.
PetVivo Holdings, Inc. (OTCQX: PETV), working alongside its wholly owned subsidiaries PetVivo Animal Health, Inc., Cosmeta Corp, and PetVivo AI, Inc., is a developing biomedical device enterprise currently concentrating on manufacturing, bringing to market, and licensing innovative medical devices and therapeutics for horses and companion animals. The Company’s approach involves leveraging human therapies for treating companion animals in a manner that saves both capital and time. A key element of this strategy is the shortened timeline to revenue for veterinary medical devices, which reach the market significantly earlier than more heavily regulated pharmaceuticals and biologics.
PetVivo maintains a strong pipeline of products intended for both animal and human treatment. A portfolio of twelve patents and six trade secrets safeguard the Company’s biomaterials, products, production processes, and methods of use. The Company’s primary product, SPRYNG® with OsteoCushion® technology, a veterinarian-administered, intra-articular injection for managing lameness and other joint-related conditions, including osteoarthritis, in cats, dogs, and horses, is currently offered for commercial sale.
Company Contact
John Lai, CEO
PetVivo Holdings, Inc.
Tel (952) 405-6216
